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Cyclic nucleotide gated (CNG) channels are a critical component of the visual
transduction cascade in the vertebrate retina. Mutations in the genes encoding
these channels have been associated with a spectrum of inherited retinal disorders.
To gain insight into their pathophysiological mechanisms, we have investigated the
functional consequences of several CNGB3 mutations, previously associated with
macular degeneration (Y469D and L595F) or complete achromatopsia (S156F, P309L,
and G558C), by expressing these subunits in combination with wild-type CNGA3 in
Xenopus oocytes and characterizing them using patch-clamp recordings in the inside-out
configuration. These mutations did not prevent the formation of functional heteromeric
channels, as indicated by sensitivity to block by L-cis-diltiazem. With the exception
of S156F, each of the mutant channels displayed electrophysiological properties
reflecting enhanced channel activity at physiological concentrations of cGMP (i.e., a
gain-of-function phenotype). The increased channel activity produced by thesemutations
resulted from either increased functional expression levels, or increased sensitivity to
cyclic nucleotides. Furthermore, L595F increased the spontaneous open probability
in the absence of activating ligand, signifying a ligand independent gain-of-function
change. In addition to the CNGB3 disease-associate mutations, we characterized
the effects of several common CNGB3 and CNGA3 single-nucleotide polymorphisms
(SNPs) on heteromeric CNGA3+CNGB3 channel function. Two of the SNPs examined
(A3-T153M, and B3-W234C) produced decreased ligand sensitivity for heteromeric CNG
channels. These changes may contribute to background disease susceptibility when
combined with other genetic or non-genetic factors. Together, these studies help to
define the underlying molecular phenotype for mutations relating to CNG channel disease
pathogenesis.
Keywords: channelopathy, cyclic nucleotide-gated channels, CNGB3, macular degeneration, gating,
single-nucleotide polymorphisms, phototransduction
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Introduction
Retinal photoreceptors are specialized neuronal cells that convert
the absorption of light energy into membrane hyperpolarization.
This electrical signal is produced by a phosphodiesterase-
mediated reduction in the concentration of cGMP, promoting
the closure of outer segment cyclic nucleotide-gated (CNG)
channels. The CNG channels participating in this cascade are
non-selective cation channels composed of CNGA and CNGB
subunits: CNGA1 and CNGB1 (A1+B1) for rod photoreceptors;
CNGA3 and CNGB3 (A3+B3) for cone photoreceptors (Craven
and Zagotta, 2006; Pifferi et al., 2006). Although CNGA and
CNGB subunits share many important structural features—
including six putative transmembrane domains, intracellular
amino, and carboxyl termini, a cyclic nucleotide binding
domain, and a conserved pore region—important functional
differences exist between these subunit types. For example,
both CNGA1 and CNGA3 can form functional homomeric
channels when expressed alone, while CNGB1 and CNGB3 fail to
form functional homomeric channels in heterologous expression
systems (Chen et al., 1993; Gerstner et al., 2000). In native
photoreceptors, CNGB subunits promote the ciliary localization
of heteromeric channels (Michalakis et al., 2006; Kizhatil et al.,
2009) and profoundly affect several critical biophysical features
of the channels including ion selectivity, ligand affinity, ligand
discrimination, and spontaneous open probability (Chen et al.,
1993; Körschen et al., 1995; Gerstner et al., 2000). Furthermore,
the presence of CNGB subunits modulates the sensitivity of CNG
channels to putative regulatory factors, such as Ca2+-calmodulin,
phosphoinsositides, and matrix metalloproteinases (Chen et al.,
1994; Brady et al., 2006; Bright et al., 2007; Meighan et al., 2012;
Rebrik et al., 2012).
The human CNGA3 and CNGB3 genes—which encode for
CNGA3 and CNGB3 subunits, respectively—each exhibit a
surprising degree of sequence variation. At present, there are
reported to be >300 single nucleotide polymorphisms within
the coding regions of human CNGA3 and CNGB3 (collectively).
A majority of these polymorphisms produce an amino acid
substitution within the primary structure. Although many
identified SNPs have a low frequency of occurrence, others are
relatively common; for example, the CNGB3 SNP, T298P, has a
reported mean allele frequency (MAP) of ∼34%1. The specific
effects of these genetic variations on CNG channel function
and photoreceptor physiology are not well understood. In
addition to benign CNG channel sequence polymorphisms, there
are currently >110 documented disease-associated mutations
in CNGA3 and CNGB3 (collectively) (Becirovic and Biel,
2013a,b). These mutations are thought to contribute to the
pathogenesis of various hereditary retinal diseases, including
macular degeneration, achromatopsia, and progressive cone
dystrophy (Kohl et al., 2000, 2004; Sundin et al., 2000; Wissinger
et al., 2001; Johnson et al., 2004; Michaelides et al., 2004;
Nishiguchi et al., 2005). Most of these mutations are linked
to achromatopsia, an autosomal recessive retinal disorder with
1NCBI Reference Assembly: CNGB3 SNP Available online at:
http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?geneId=54714 [Accessed
August 11, 2014].
absent or limited cone photoreceptor function but normal rod
function, impaired color vision, reduced visual acuity, congenital
photophobia, and nystagmus. Although a greater variety of
specific mutations in CNGA3 have been linked to achromatopsia
compared to mutations in CNGB3, mutations in CNGA3 only
account for 20–30% of the known cases (Wissinger et al., 2001;
Johnson et al., 2004). In contrast, mutations in CNGB3 are
responsible for 40–50% of the cases (Kohl et al., 2004). Although
several studies have characterized the functional consequences of
cone CNG channels containing disease-associated mutations in
CNGA3 and CNGB3 subunits (Peng et al., 2003b; Okada et al.,
2004; Tränkner et al., 2004; Bright et al., 2005; Muraki-Oda et al.,
2007; Reuter et al., 2008; Duricka et al., 2012; Liu et al., 2013;
Tanaka et al., 2014), the range of molecular phenotypes associated
with these mutations remains incompletely explored.
In order to better understand the molecular and
pathophysiological mechanisms underlying disease-associated
mutations in cone CNG channels, we have examined the
functional properties of cone CNG channels containing five
previously uncharacterized mutations in CNGB3. Two of these
mutations [Y469D and L595F (Nishiguchi et al., 2005)], are
linked to macular degeneration (MD)/Stargardt’s disease, which
affects the central regions of the retina leading to a loss of central
vision. Three of these mutations [S156F, P309L (Kohl et al.,
2004), and G558C (Nishiguchi et al., 2005)] have been linked to
achromotopsia. With the exception of S156F, each of the mutant
channels examined here produced a gain-of-function phenotype,
with the two MD-associated mutations producing the most
dramatic changes in CNG channel function.
Materials and Methods
Molecular Biology and Functional Expression
For heterologous expression in Xenopus laevis oocytes, the
coding sequences for human CNGA3 (Yu et al., 1996) and
CNGB3 (Peng et al., 2003a) were subcloned into pGEMHE (Peng
et al., 2004). Site-directed mutagenesis of CNGA3 and CNGB3
was carried out as previously described (Peng et al., 2003a).
Oocytes were isolated and microinjected with ∼5 ng of mRNA
(for all constructs); mRNA concentrations were determined
and relative amounts standardized by both denaturing gel
electrophoresis and UV spectroscopy. The animal use protocols
were consistent with the recommendations of the American
Veterinary Medical Association and were approved by the
Institutional Animal Care and Use Committee of Washington
State University. Eachmutant channel construct was examined in
at least four independent oocyte injection batches, and compared
to wild-type channels within the same injection batch. For
efficient generation of heteromeric channels, the ratio of CNGA3
mRNA to CNGB3 mRNA was 1:2.5 (Peng et al., 2004).
Electrophysiology
One to 7 days after microinjection of mRNA, patch-clamp
experiments were performed in the inside-out configuration.
Recordings were made at 20–23◦C. Voltage control was provided
by an Axopatch 200B amplifier (Molecular Devices, Sunnyvale,
CA; formerly Axon Instruments); macroscopic current data were
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acquired using Pulse software (HEKA Elektronik, Lambrecht,
Germany) with a sampling frequency of 25 kHz, and low-pass
filtered at 10 kHz. Initial pipette resistances were 0.4–0.8 M.
From a holding potential of 0mV, currents were elicited
by voltage steps to +80mV, then to −80mV, and back
to 0mV. Intracellular and extracellular solutions contained
130mM NaCl, 0.2mM EDTA, and 3mM HEPES (pH 7.2). The
cyclic nucleotides, cAMP or cGMP (Sigma-Aldrich, St. Louis,
MO), were added to intracellular solutions as indicated. The
intracellular solution applied to the face of the patch was changed
using an RSC-160 rapid solution changer (Molecular Kinetics,
Indianapolis, IN).
Data Analysis
Currents were leak subtracted using the current traces elicited in
the absence of cyclic nucleotides before analysis unless otherwise
indicated. For channel activation by cGMP dose-response data
were fit using the Hill equation: I/IMAX = [cNMP]
nH/(K1/2
nH+
[cNMP]nH), where I is the current amplitude, IMAX is the
maximum current elicited by saturating concentration of ligand,
[cNMP] is the ligand concentration, K1/2 is the apparent ligand
affinity, and nH is theHill slope. Fitting with theHill equation was
accomplished with Octave, an open source data-analysis package
(www.octave.org), using a custom-fitting routine based on the
method of steepest descent.
The maximum and spontaneous open probabilities were
measured using non-stationary fluctuation analysis (see Alvarez
et al., 2002 for review). For the maximum open probability,
mean isochrone current variances across 10 current traces
were measured for each cGMP concentration. The mean
current variance elicited in the absence of cyclic nucleotide was
subtracted from the cGMP-elicited variances. Mean variances
were plotted against their respective mean macroscopic current
amplitudes and were fit with the following parabolic equation:
σ 2 = iI −
(
I2
N
)
where σ 2 is the meanmacroscopic current variance, I is the mean
macroscopic current amplitude, i is the single-channel current
amplitude, and N is the number of conductive channels in the
membrane patch. The maximum open probability (PO,MAX) was
calculated using the following relationship:
PO,MAX =
IMAX
iN
To calculate the spontaneous open probability (PO,SP) for wild-
type and mutant channels, we used the relationship between
the spontaneous macroscopic current variance (i.e., the current
variance in the absence of ligand) and the estimated number
of channels in the membrane patch (using the relationship
above). The macroscopic current variance was determined by the
following:
σ 2 = Ni2POq
where PO is the open probability, and q is the closed probability
(and q = 1-PO). Differentiating the current variance with
respect to the number of channels (dσ 2/dN) yields the following
quadratic equation:
dσ 2
dN
= i2PO (1− PO)
Solving for PO produces an expression for the spontaneous open
probability as a function of dσ 2/dN and i:
PO,SP =
−
√
i2 − 4 dσ
2
dN
− i
2i
To calculate PO, we used the average measurements of i from
fluctuation analyses for each channel type: A3WT: i = 3.3
pA; A3+B3WT: i = 3.1 pA; A3+B3L595F: i = 3.4 pA. The
unitary current measurements (at +80mV) for heteromeric
wild-type channels are in reasonable agreement with previous
investigations using single-channel recordings under identical
conditions (Peng et al., 2003b) or previous investigations of
homomeric channels under similar buffering conditions (Yu
et al., 1996; Meighan et al., 2012).
Statistical Analysis
ANOVAs, single-pairwise and multiple-pairwise comparisons
were performed with NCSS (www.NCSS.com). Data were tested
for normality and equal variance prior to hypothesis testing.
Single pairwise comparisons of normally-distributed and equal-
variant (NDEV) data were analyzed with the Student’s t-test;
multiple pairwise comparisons of NDEV data were analyzed with
the Holm-Bonferroni corrected t-test (Holm, 1979) following
a statistically significant ANOVA result. Data that violated
assumptions of normality and equal variance were analyzed with
Kruskal-Wallis and Mann-Whitney U-tests as indicated. A p-
value less than 0.05 was considered to be statistically significant
for all hypothesis tests. All values are reported as the mean ±
S.E.M. of n experiments (patches) unless otherwise indicated.
Results
Mutant CNGB3 Subunits Form Functional
Heteromeric CNG Channels with CNGA3
We investigated the functional consequences of five disease-
associated mutations in human CNGB3, the cone photoreceptor
CNG channel β subunit (Figure 1A). Mutations were introduced
into CNGB3 cDNA and these subunits were co-expressed
from transcribed cRNA in Xenopus oocytes with human
cone CNG channel α subunits (CNGA3). Previous reports
have characterized CNGB3 mutations that produce non-
functional CNGB3 subunits (e.g., T383fsX), which fail to form
heteromeric channels when coexpressed with CNGA3, resulting
in homomeric CNGA3-only channels (Peng et al., 2003b; Liu
et al., 2013). Therefore, we first tested for functional expression of
heteromeric channels by application of the CNG channel blocker
L-cis-diltiazem in the presence of a saturating concentration of
cGMP (1mM). Application of diltiazem to the cytoplasmic face
of the membrane blocks native and recombinant heteromeric
CNG channels containing CNGB3 (or CNGB1) subunits, but
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FIGURE 1 | CNGB3 disease-associated mutations impart a
gain-of-function phenotype in heteromeric CNG channels. (A) Diagram
showing CNGB3 subunit topology with approximate locations of disease
associated mutations examined in this paper. (B) Representative current
traces from inside-out patches excised from Xenopus oocytes expressing
heteromeric human A3+B3 channels activated by a saturating concentration
(1mM) of cGMP in the presence (arrowhead) or absence of 25µM
L-cis-diltiazem. Current traces were elicited using voltage steps from a holding
potential of 0mV, to +80mV, −80mV, and then returning to 0mV. (C) Box
plots summarizing the sensitivity to diltiazem block of channels containing
disease-associated mutations compared to wild type A3+B3 heteromeric (WT)
and CNGA3-only homomeric channels (A3). Data are expressed as the ratio of
the 1mM cGMP current amplitude at +80mV in the presence and absence of
diltiazem (as in B). Boxes represent 25th–75th percentiles, lines show the
median, and whiskers represent the 5th–95th percentiles. (D) Summary of
current densities at 5µM cGMP for CNGB3 disease-associated mutations.
Current-density estimates are based on cGMP dose-response data and
estimates of patch area using patch electrode resistance (Sakmann and
Neher, 1995). Four of the five mutations examined had an increase in the 5µM
current density compared to wild type A3+B3 channels (p < 0.001,
single-factor ANOVA, n = 6–23; Holm’s t-test, **p < 0.01, ***p < 0.001).
exerts only minimal block on homomeric CNGA3 channels
(McLatchie and Matthews, 1992; Chen et al., 1993; Gerstner
et al., 2000; Peng et al., 2003a). For each of the mutations
examined, application of diltiazem to excised inside-out patches
reduced the cGMP-stimulated current amplitude (Figures 1B,C).
The level of diltiazem block for the mutant channels was
statistically indistinguishable from wild type (WT) heteromeric
channels (p > 0.05, single-factor ANOVA, n = 4–11). This
indicates that each of the CNGB3 mutations examined did not
interfere with the formation of functional heteromeric A3+B3
channels.
The photoreceptor “dark current” is normally produced by
a subsaturating concentration of cGMP (2–5µM), eliciting a
low probability of channel opening (i.e., PO < 0.1) (Pugh and
Lamb, 1990). Many retinal diseases are thought arise from a
deleterious enhancement in CNG channel activity, promoting
photoreceptor cell death (Peng et al., 2003b; Bright et al., 2005;
Paquet-Durand et al., 2011; Liu et al., 2013). Therefore, we
tested whether the disease-associated mutations described above
alter the current amplitude relative to the patch area (i.e., the
current density) produced by a subsaturating concentration of
cGMP. For most of the mutant channels examined (P309L,
Y469D, G558C, and L595F), we observed a significant increase
in the subsaturating current density relative to WT channels
(Figure 1D). Therefore, increased CNG channel activity may be
a shared feature for channels containing a subset of CNGB3
disease-associated mutations.
The macroscopic current amplitude (I) is determined by the
single channel current amplitude (i), the number of conductive
channels (N) and the channel open probability (PO), where
I = iNPO. Because each of the mutations examined here are
distant from the channel pore-forming region, we expect that
the increased subsaturating current densities described above
are most likely caused by: (1) increased functional expression
of heteromeric A3+B3 channels (increasing N); and/or (2)
increased sensitivity to cGMP (increasing PO). To differentiate
between these possibilities, first we measured the current
density produced by a saturating concentration of cGMP (i.e.,
the maximum current density). The CNGB3 P309L mutation
significantly increased the maximum current density compared
to wild-type channels (median [25th and 75th percentiles] in
pA/µm2: WT = 41.0 [18.4, 134.5]; P309L = 206.5 [153.7,
658.0]; p < 0.01, Mann Whitney U, n = 5–16). The other
CNGB3 mutations had no significant effect on the maximum
current density (data not shown). The extent by which P309L
increased the maximum current density (5.0 times greater than
WT) parallels the extent by which the mutation increased the
subsaturating current density (4.8 times greater than WT; see
Figure 1D). Accordingly, the increased subsaturating current
density caused by P309L is likely due to increased functional
expression of the mutant channels (i.e., increased N).
Effects of CNGB3 Disease-associated Mutations
on Channel Ligand Sensitivity
Results described above suggest that the increased subsaturating
current observed for Y469D-, G558C- or L595F-containing
channels is not due to altered functional expression levels for
heteromeric CNG channels (i.e., not an effect on N). Therefore,
we tested whether these disease-associated mutations alter the
gating properties of A3+B3 heteromeric channels (thereby
changing PO at subsaturating concentrations of cGMP). First,
we examined the effects of the CNGB3 mutations on the
apparent cGMP affinity (K1/2 cGMP) of A3+B3 channels. Dose-
response data were collected and fit using the Hill equation.
Two of the mutations, Y469D and L595F, each produced a
significant decrease in K1/2 cGMP (i.e., increased apparent
affinity) compared toWT channels (Figures 2A,B). Furthermore,
Y469D, G558C, and L595F each significantly reduced the Hill
coefficient for the cGMP dose-response relationship relative to
WT (Figures 2A,C). The reduced Hill coefficients may arise
from a change in cooperativity or altered gating properties
(e.g., a reduction in the number of activated subunits necessary
to promote channel opening) (see Colquhoun, 1998). The
increased apparent affinity for cGMP (for Y469D and L595F)
and/or reduced Hill coefficient (for Y469D, G558C, and L595F)
produced an enhancement in current elicited by 5µM cGMP,
relative to the maximum cGMP stimulated current (IMAX) for
Frontiers in Physiology | www.frontiersin.org 4 June 2015 | Volume 6 | Article 177
Meighan et al. CNGB3 macular degeneration-associated mutations
FIGURE 2 | Macular degeneration-associated Y469D and L595F
mutations in CNGB3 each increase the sensitivity of heteromeric
A3+B3 channels to physiological ligands. (A) Representative
dose-response curves for activation of A3+B3 wild type (WT; filled circles),
A3+B3Y469D (Y469D; open circles), A3+B3G558C (G558C; open triangles),
and A3+B3L595F (L595F; open squares) channels by cGMP. Currents
were normalized to the maximum cGMP current (IMAX = 1.0). Continuous
curves represent fits of the dose-response relationship to the Hill equation
as indicated in the Materials and Methods. Best-fit parameters are as
follows: WT, K1/2 = 15µM, nH = 2.4; Y469D, K1/2 = 10µM, nH = 1.4;
G558C, K1/2 = 13µM, nH = 2.1; L595F, K1/2 = 5.7µM, nH = 2.1.
Shaded area represents approximate physiological cGMP concentration in
photoreceptors in the dark (Pugh and Lamb, 1993). (B) Summary of
apparent cGMP affinity (K1/2) for channels formed by CNGA3 with
wild-type CNGB3 or CNGB3 having indicated disease-associated
mutations. Data are based on best-fit Hill curves and expressed as mean
K1/2 (± S.E.M.). The K1/2 cGMP was significantly reduced for the Y469D
and L595F groups compared to wild type (p < 0.001, Kruskal-Wallis,
n = 12–22; ***p < 0.001, Mann-Whitney U-test). (C) Summary of mean Hill
coefficients (nH) for channels formed by CNGA3 with wild-type CNGB3 or
CNGB3 having disease-associated mutations. The nH was significantly
reduced for the Y469D, G558C, and L595F groups compared to wild type
(p < 0.001, single-factor ANOVA, n = 5–9; ***p < 0.001, **p < 0.01 Holm’s
t-test). (D) Representative current traces of heteromeric human A3+B3
channels after activation by a sub-saturating concentration of cGMP
(5µM). Currents were scaled to the maximum current (IMAX ) in a
saturating concentration of cGMP (1mM) as illustrated by the WT current
traces. Relative sub-saturating current amplitudes (I5µM/IMAX ) are as
follows: WT = 0.05; Y469D = 0.25; G558C = 0.13; L595F = 0.43. (E)
Representative current traces after activation by a saturating concentration
of cGMP (1mM, black line) or a saturating concentration of cAMP (10mM,
gray line). (F) Summary of relative agonist efficacy (IcAMP/IcGMP) for
channels containing wild-type CNGB3 or disease-associated mutations,
expressed as mean (± S.E.M.). The efficacy of cAMP was significantly
enhanced for the Y469D and L595F channels compared to wild type
(p < 0.001, Kruskal-Wallis, n = 5–12; ***p < 0.001, Holm’s t-test).
Y469D-, G558C-, and L595F-containing channels (Figure 2D).
Additionally, channels containing Y469D and L595F mutations
exhibited an increase in the relative agonist efficacy of cAMP—a
partial agonist for cone photoreceptor channels (Figures 2E,F).
The other mutations examined (S156F and P309L) did not
significantly alter channel gating. Collectively, these results
suggest that the increased current density for Y469D, G558C,
and L595F (see Figure 1D) is likely due to changes in PO at
subsaturating concentrations of cGMP.
To further characterize the effects of these CNGB3 mutations
on channel gating, we tested whether the mutations altered
the absolute agonist efficacies of cGMP and cAMP, as these
parameters report channel-gating properties after all ligand-
binding sites have been occupied. To address this issue,
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FIGURE 3 | Effects of CNGB3 disease-associated mutations on the
absolute agonist efficacy of cGMP and the spontaneous open
probability. (A, Left) Overlay of four current traces from A3+B3 channels,
activated by a sub-saturating concentration of cGMP (25µM) to produce an
approximately half-maximal current amplitude. Shaded area indicates the
region of interest (ROI) used for the calculation of mean current and mean
isochrone variance for each concentration of cGMP. (A, Right) ROI overlays at
various cGMP concentrations (µM cGMP indicated on the right). Current and
variance calculations were performed as described in the Materials and
Methods. The mean isochrone variance is minimal at extreme low and high
open probabilities and maximizes at 50% open probability. For wild type cone
CNG channels, ∼50% open probability is achieved at cGMP concentrations
near the K1/2. The mean isochrone variance at saturating cGMP (i.e., 1mM)
reflects the maximum open probability (PO,MAX ), such that a decreased
variance indicates an increased PO,MAX (provided that PO,MAX > 50%). (B)
Current-variance plot for A3+B3 wild type (closed circles) and A3+B3L595F
(open circles) after activation by cGMP at +80mV. The L595F mean current
and variance estimates were scaled to WT IMAX to facilitate comparison of the
initial slope from zero current and the variance at saturating ligand
concentrations. Continuous lines produced by fitting with a 2nd order
polynomial, as described in the Materials and Methods, using the following
best-fit parameters: WT (solid), i = 3.1 pA, N = 1550 channels; L595F
(hashed), i = 3.2 pA, N = 1370 channels. The mean variance at saturating
cGMP is reduced for L595F channels (gray arrowhead) compared to WT
channels (black arrowhead), indicating an increased PO,MAX for L595F
channels. (C) Summary of maximal open probabilities after activation with
saturating cGMP (1mM). Maximal open probabilities were calculated as
described in the Materials and Methods. The PO,MAX was significantly
increased for Y469D and L595F channels compared to wild type (p < 0.01,
single-factor ANOVA, n = 4–9; Holm’s t-test, *p < 0.05, **p < 0.01).
(Continued)
FIGURE 3 | Continued
(D) Summary of unitary conductance values based on best-fit polynomials
described in (B). The CNGB3 disease-associated mutations did not
significantly alter the unitary conductance (p = 0.28; single-factor ANOVA). (E)
Relationship between the spontaneous isochrone variance (σ2SP) and
estimated number of channels (N) in the membrane patch for WT (black
circles), L595F (open circles) and A3 only (gray circles) containing channels.
The σ2SP and N estimates were determined as described in the Materials and
Methods. Data fit with linear models using the following best-fit slopes (with
the units: A2/channel x10−26): A3+B3 WT = 1.53; A3+B3 L595F = 4.98; A3
WT = 0.58. The slope of the relationship between σ2SP and N (dσ
2
SP/dN)
was elevated for L595F channels compared to WT, reflecting an increase in the
spontaneous open probability (PO,SP) for L595F channels. (F) Spontaneous
open probabilities were calculated from trend-line slopes (dσ2SP/dN) from E.
PO,SP calculations were based on the relationship: dσ
2/dN = i2Poq, as
described in Materials and Methods. Error estimates of PO,SP were
propagated from the standard error of slopes from (E). We observed that the
spontaneous open probability is significantly lower for A3 homomeric channels
(A3WT, PO,SP = 0.50×10
−3) compared WT heteromeric channels (A3+B3
WT, PO,SP = 1.6 x10
−3) (***p < 0.001, extra sum-of-squares F-test, n = 6,7).
These estimates are in reasonable agreement with previous characterization of
mouse cone CNG channels (Gerstner et al., 2000). We also observed that the
PO,SP is significantly increased for L595F-containing channels (A3+B3 L595F,
PO,SP = 4.3 ×10
−3) compared to WT heteromeric channels (**p < 0.001,
extra sum-of-squares F-test, n = 7,8), reflecting a change in the intrinsic
gating properties of L595F-containing channels.
we determined the maximum open probability (PO,MAX)
in a saturating concentration of cGMP for wild-type and
mutant channels using non-stationary fluctuation analysis. Mean
currents and isochrone variances were measured and PO,MAX
was calculated as described in the Materials and Methods
(Figures 3A,B). We observed that the PO,MAX for CNGB3
mutants Y469D and L595F were increased relative to wild type
(Figures 3B,C). Based on these PO,MAX values, we estimated
the following maximum cAMP stimulated open probabilities
(mean PO,cAMP): WT = 0.18 ± 0.02; Y469D = 0.43 ± 0.03;
L595F = 0.42 ± 0.02. Additionally, we used fluctuation analysis
to measure the single channel current amplitude of wild type
andmutant channels. This method produced estimates of unitary
conductance for heteromeric WT channels (γ = 38.5 ± 2.5
pS) that is reasonably consistent with previous studies utilizing
single-channel recordings under identical buffer conditions
(Peng et al., 2003b). Furthermore, we observed that each CNGB3
mutation did not significantly alter the unitary conductance of
heteromeric channels (Figure 3D).
For the Y469D mutation, increased apparent cGMP affinity
and cGMP efficacy, concomitant with increased cAMP efficacy,
collectively suggests that this mutation may enhance the intrinsic
(ligand independent) gating properties of heteromeric CNG
channels (for review see Colquhoun, 1998). Interpreting the
effects of the L595F mutation on channel gating is problematic,
however, because this mutation resides within the cNMP-binding
domain; it is plausible that the L595F mutation produces a
gain-of-function phenotype by altering ligand-dependent and/or
the ligand-independent gating properties. To address these
possibilities, we examined the spontaneous open probability
of L595F-containing channels relative to wild-type channels.
We expect that if the L595F mutation solely affects ligand
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dependent gating properties, then the channel’s spontaneous
open probability (PO,SP) would be unaffected by this mutation.
We analyzed the relationship between the spontaneous current
variance (σ 2SP) and the number of functional channels in the
membrane patch (N). The slope of this relationship (dσ 2SP/dN)
reports the spontaneous open probability, as described in the
Materials and Methods. Channels containing CNGB3-L595F
subunits exhibited an increase in dσ 2SP/dN relative to wild-type
channels (Figure 3E). Next we used the best-fit slopes of the
σ 2SP and N relationships (from Figure 3E) to calculate PO,SP for
mutant and wild-type channels. This method produced PO,SP
estimates for wild type human homomeric A3-only (PO,SP =
0.50 ×10−3) and heteromeric A3+B3 (PO,SP = 1.6 × 10
−3)
compositions that are roughly comparable to previous reports
of PO,SP for channels comprised of mouse CNGA3 and CNGB3
subunits (Gerstner et al., 2000). Furthermore, as indicated by the
increase in dσ 2SP/dN above, we found that the L595F mutation
significantly increased spontaneous open probability (PO,SP =
4.3 × 10−3) (Figure 3F). This finding indicates that the L595F
mutation enhances intrinsic (ligand-independent) gating of CNG
channels; however, this does not rule out the possibility that
additional ligand-specific effects on gating arise from the L595F
mutation.
Effects of CNGB3 Single-nucleotide
Polymorphisms on Channel Ligand Sensitivity
Single nucleotide polymorphisms (SNPs) contribute to the
genetic diversity within a species and can affect the susceptibility
to disease or disease progression. A number of SNPs have been
identified for human CNGA3 and CNGB3, but it is unknown
how they affect the functional properties of heteromeric CNG
channels. To address this issue, three relatively common CNGB3
SNPs (W234C, T298P, or M466T) were introduced into cDNA
encoding the human CNGB3 subunit, and were co-expressed
with wild type human CNGA3 subunits in Xenopus oocytes. The
rationale for selecting these SNPs was based on the following:
each of these SNPs has a high frequency of occurrence (i.e.,
MAP) relative to other SNPs; each site exhibits high sequence
conservation across orthologous and parologous sequences; and
each SNP represents a non-conservative amino acid change
relative to the reference sequence.We also examined one CNGA3
SNP, T153M, in the context of heteromeric channels after co-
expression with wild type human CNGB3 subunits.
We first confirmed expression of heteromeric CNG channels
by application of diltiazem (as in Figures 1B,C). Based on the
observed sensitivity to diltiazem block (Figure 4A), each of
the SNPs examined formed functional heteromeric channels.
Next, we assessed the impact of the CNGA3 and CNGB3
SNPs on apparent affinity for cGMP and the relative efficacy
of cAMP. Two of the SNPs examined, CNGB3-W234C and
CNGA3-T153M, produced a significant increase in K1/2 cGMP
(decreased apparent affinity) for heteromeric channels relative
to WT channels (Figure 4B). Consistent with the effects on
cGMP apparent affinity, these SNPs also decreased the relative
efficacy of cAMP (Figure 4C). Furthermore, the gating effects
produced by CNGA3-T153M in heteromeric channels effected
a significant reduction in subsaturating current relative to
WT (Figure 4D). Other SNPs examined (T298P and M466T)
produced no significant changes in the gating properties of
heteromeric channels.
Interestingly, the CNGA3-T153M SNP, which decreased the
ligand sensitivity of heteromeric channels, failed to significantly
alter the gating properties of homomeric A3-only channels
(Figures 4B,C). To further characterize the impact of the
CNGA3-T153M SNP on homomeric and heteromeric channel
function, we examined the maximum open probability for
channels having the CNGA3-T153M SNP relative to reference
channel compositions. Mean currents and isochrone variances
were measured (Figure 5A) and PO,MAX was calculated as
described above (see Figure 3). Consistent with the gating
effects described above, T153M containing homomeric channels
exhibited a PO,MAX that was statistically indistinguishable
from wild type A3-only channels (Figure 5B); in contrast,
T153M containing heteromeric channels exhibited a significant
reduction in PO,MAX relative to wild-type channels (Figure 5B).
Thus, the CNGA3-T153M SNP imparts a profound loss-of-
function phenotype that only manifests in the context of A3+B3
heteromeric channels.
Discussion
We have characterized the functional effects of several disease-
associated mutations in CNGB3 (S156F, P309L, Y469D, G558C,
and L595F). Most of the mutations examined here produced a
gain-of-function phenotype, causing increased current levels at
physiological concentrations of cGMP (Figure 6). This finding
is consistent with the hypothesis that abnormally elevated CNG
channel activity is causally linked to photoreceptor dysfunction
and retinal degeneration (Paquet-Durand et al., 2011; Liu et al.,
2013). Additionally, we described the functional effects of
common single nucleotide polymorphisms for CNGB3 (W234C,
T298P, and M466T) and CNGA3 (T153M). In contrast to the
disease-associated mutations, the SNPs examined here either
failed to impact channel function, or produced a loss-of-function
phenotype, resulting in decreased current levels at physiological
concentrations of cGMP (Figure 6). These results demonstrate
that common SNPs in CNG channel genes can alter channel
function, and thus may influence disease susceptibility and
progression in the context of other mutations or environmental
factors.
There are several mechanisms that may promote a deleterious
elevation in CNG channel activity in photoreceptors. For the
CNGB3 mutations examined here, we observed increased
subsaturating current by three mechanisms. First, the
achromatopsia-associated mutation, P309L, produced a
gain-of-function phenotype by increasing functional expression
levels in oocytes. It is unknown whether the increased channel
density caused by P309L is due to increased trafficking to the
plasma membrane, or decreased turnover of channel protein.
Although this result is consistent with the presumed connection
between CNG channel hyperactivity and photoreceptor cell
death, extrapolation from heterologous expression systems to
photoreceptors requires discretion. Furthermore, we cannot
rule out the possibility that P309L contributes to the etiology
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FIGURE 4 | Effects of single nucleotide polymorphisms on ligand
sensitivity of heteromeric A3+B3 channels. (A) CNGA3 and CNGB3
single nucleotide polymorphisms (SNPs) examined here form functional
A3+B3 heteromeric channels. Box plots summarizing the sensitivity to
block by 25µM diltiazem in the presence of 1mM cGMP for
SNP-containing channels compared to wild type A3+B3 and A3-only
channels. (B) Summary of K1/2 cGMP for wild type and SNP-containing
A3 or A3+B3 channels. Data are based on best-fit Hill parameters and
expressed as mean K1/2 (± S.E.M.). The K1/2 cGMP was significantly
increased for the A3+B3W234C and A3T153M+B3 groups compared to
wild type A3+B3 channels (p < 0.001, single-factor ANOVA, n = 4–7;
Holm’s t-test, **p < 0.01, ***p < 0.001). There was no significant difference
between wild-type A3 and A3T153M homomeric channels (Holm’s t-test,
p > 0.05). (C) Summary of relative agonist efficacy for wild type and
SNP-containing A3 or A3+B3 channels. The relative efficacy of cAMP was
significantly decreased for A3+B3W234C and A3T153M+B3 channels
compared to wild type A3+B3 channels (p < 0.001, Kruskal-Wallis,
n = 4–7; Holm’s t-test, *p < 0.05). There was no significant difference
between wild-type A3 and A3T153M homomeric channels (Student’s t-test,
p > 0.05). (D) Summary of 5µM cGMP current densities for select CNG
channel polymorphisms. The estimated 5µM current density for
heteromeric A3T153M+B3 channels was decreased compared to wild type
A3+B3 channels (p < 0.05, single-factor ANOVA, n = 4–8; Holm’s
t-test, *p < 0.05).
of achromatopsia by altering other photoreceptor-specific
processes, such as adaptive changes in channel sensitivity.
Further studies are needed to determine how this mutation
promotes increased channel surface expression, and whether this
result translates to altered expression levels in photoreceptors.
Second, two macular degeneration/Stargardt’s disease-associated
mutations, Y469D and L595F, each produced a gain-of-function
phenotype by altering CNG channel gating. Channels containing
either Y469D or L595F demonstrated increased sensitivity to
their endogenous ligands; thus, increased open probability
is expected at physiological concentrations of cGMP. Third,
the achromatopsia associated G558C mutation produced a
gain-of-function phenotype by reducing the Hill coefficient of
the dose-response relationship for cGMP. Although this result
could not be attributed to changes in the apparent affinity for
cGMP, a reduced Hill coefficient increases channel activity at
cGMP concentrations below the K1/2. Similarly, the reduced Hill
coefficient for the Y469D and L595F mutations contributes to
the gain-of-function phenotype observed with these mutations.
Since photoreceptor cGMP concentrations are thought to be
about 2–5µM in the dark (Pugh and Lamb, 1993), changes in
CNG channel responses below the K1/2 cGMP are expected to be
physiologically important.
In addition to these ligand dependent changes in channel
function, we observed an increase in the spontaneous (i.e.,
unliganded) open probability for L595F-containing channels
compared to wild-type channels. This result is intriguing
considering that CNG channel closure is a critical event within
the phototransduction cascade. This suggests that CNGB3
mutations could plausibly interfere with channel deactivation
during light stimulation and contribute to the background
conductance in the photoreceptor—a ligand-independent, gain-
of-function change. Furthermore, this ligand-independent effect
was somewhat unexpected, considering that L595F resides within
the CNBD. How might a mutation within the CNBD exert
a global effect on channel gating? L595 represents a highly
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FIGURE 5 | CNGA3-T153M polymorphism decreases the maximum
open probability for heteromeric but not homomeric CNG channels. (A)
Current-variance plot for A3T153M homomeric (open circles) and A3T153M+B3
(closed circles) channels following activation by various concentrations cGMP
at +80mV (as in Figure 3). Continuous lines were produced by fitting with a
2nd-order polynomial using the following best-fit parameters: A3T153M (solid),
i = 2.5 pA, N = 370 channels; A3T153M+B3 (hashed), i = 2.5 pA, N = 370
channels. Arrows denote mean variance at saturating cGMP for A3T153M
(solid) and A3T153M+B3 (hashed). (B) Maximum open probability was
decreased for heteromeric A3T153M+B3, but not homomeric A3T153M
channels compared to wild-type channels (***p < 0.001, Student’s t-test,
n = 4–8).
conserved leucine located within the phosphate binding cassette
(PBC) of the canonical cyclic nucleotide binding domain;
the PBC interacts with phosphate and ribose moieties of the
cyclic nucleotide upon ligand binding. The increase in the
spontaneous open probability suggests that L595 influences
the allosteric transition underlying channel opening and that
the L595F mutation stabilizes the open state relative to the
closed state. Based on NMR spectroscopy of Mesorhizobium loti
K1 (MloK1) channels and double electron–electron resonance
(DEER) spectroscopy of HCN channels, the PBC participates in
the allosteric conformational change within the CNBD (Schünke
et al., 2011; Puljung et al., 2014). Interestingly, NMR spectroscopy
indicates that the homologous leucine residue within the PBC
of MloK1 (L301) is significantly displaced upon ligand binding.
The authors speculate that in the absence of ligand, the L301 side
chain contributes to a hydrophobic pocket that sterically prevents
the B and C helices of the CNBD from assuming the ligand-
bound position. Ligand binding promotes the repositioning of
L301 thus permitting the B and C helices to shift toward the β roll
FIGURE 6 | Gain-of-function/loss-of-function continuum for cone CNG
channel disease-associated mutations and polymorphisms based on
current densities at a physiological concentration of cGMP. Plot
comparing 5µM current density ratios for CNGB3 disease associated
mutations and CNG channel polymorphisms with wild type A3+B3 channels
(star). The plot includes CNGB3 disease-associated mutations described here
(open circles) and several CNGB3 disease-associated mutations described
previously (Peng et al., 2003b—open triangles; Bright et al., 2005—open
squares). Channels with a current-density ratio greater than 1.0 are predicted
to generate an elevated photoreceptor dark current compared to wild type
A3+B3 channels and thus can be characterized as having a putative
gain-of-function phenotype. Conversely, channels with a current-density ratio
less than 1.0 are predicted to generate an attenuated photoreceptor dark
current compared to wild type channels and can thus be characterized as
having a putative loss-of-function phenotype.
during the allosteric conformational change. NMR spectroscopy
and DEER measurements of conformational rearrangements in
the CNBD ofHCN2 also imply repositioning of the PBC (Puljung
et al., 2014; Saponaro et al., 2014). Assuming L595 in CNGB3
similarly contributes to the gating movements in the CNBD,
we speculate that the leucine-to-phenylalanine mutation exerts
ligand-independent effects on the conformation of the PBC
and/or the B and C helices, which make this allosteric transition
more favorable.
In the context of photoreceptor function, the mutations
producing a gain-of-function phenotype described above (see
Figure 6) are expected to enhance CNG channel activity in
the dark (i.e., increase the “dark current”). CNG channels
provide the main calcium entry pathway for photoreceptor
outer segments (Fain et al., 2001; Korenbrot and Rebrik, 2002).
Additionally, it has been demonstrated that hyperactivity of
CNG channels—either due to elevated basal cGMP levels (from
loss of phosphodiesterase activity or increased guanylate-cyclase
activity) or increased channel sensitivity to cGMP—promotes
photoreceptor cell death via calcium-dependent mechanisms
(Huang et al., 1995; Payne et al., 1998; Biel and Michalakis,
2007; Paquet-Durand et al., 2011; Liu et al., 2013). Consistent
with this idea, CNG channel knockout or knockdown can
rescue photoreceptors in the context of mutations producing
elevated cGMP levels (Paquet-Durand et al., 2011; Tosi et al.,
2011). In addition, CNG channel block using L-cis-diltiazem
can in several scenarios rescue cell viability in the context of
disease-associated perturbations (Frasson et al., 1999; Vallazza-
Deschamps et al., 2005; Liu et al., 2013). Thus, CNG channels
may represent a logical target for intervention in some forms of
retinal degeneration.
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In contrast to the functional perturbations described for
the other disease-associated mutations, S156F produced no
significant change in CNG channel behavior. The S156F
mutation has been reported in multiple families having the
clinical features of achromatopsia (Kohl et al., 2004). S156F
may affect some feature other than the basal channel activity
measured here, such as mRNA splicing or protein stability in
photoreceptors. S156F alsomight influence channel regulation by
second messengers, as it represents a potential phosphorylation
site and is adjacent to the N-terminal calmodulin-binding site in
human CNGB3 (Peng et al., 2003a). Furthermore, S156 is located
within a region of CNGB3 that is not highly conserved (the
cytoplasmic N-terminal domain); this residue is present in many
but not all orthologous sequences. It remains possible that S156F
represents a non-pathogenic sequence variation, perhaps linked
to an unknown sequence change in a non-protein coding region
of CNGB3 that might alter mRNA expression levels, processing
or stability.
We observed that the SNP T153M in CNGA3 decreased
the ligand sensitivity of heteromeric A3+B3 channels but not
homomeric A3-only channels. This finding is relevant as this
mutation was observed in the genetic analyses of two patients
(sisters) diagnosed as incomplete achromats (Kohl et al., 1998;
Tränkner et al., 2004). The gating effects produced by T153M
were surprising as it had been previously noted that this sequence
change does not alter the gating properties of CNG channels
(Tränkner et al., 2004). This conclusion was likely based on
the previous characterization of T153M being restricted to
homomeric (A3 only) channels; similarly, we observe no effect
of T153M on homomeric channel function. How might T153M
alter the gating properties of A3+B3 heteromeric, but not A3
homomeric channels? One possibility is that T153M alters A3/B3
intersubunit interactions in heteromeric channels, but not A3/A3
interactions in homomeric channels. Intersubunit interactions
modulate the ligand sensitivity of CNG channels, and are
regulated by a variety of signaling effectors, including Ca2+-
calmodulin (Trudeau and Zagotta, 2002; Zheng et al., 2003) and
phosphoinositides (PIPn) (Brady et al., 2006; Dai and Varnum,
2013; Dai et al., 2013). Furthermore, the interactions between
subunits—and the modulation of intersubunit interactions
by signaling effectors—can depend on channel composition
(i.e., homomeric vs. heteromeric). For example, it has been
demonstrated recently that PIPn-mediated regulation of cone
CNG channel ligand sensitivity requires regulation modules
located within CNGA3 subunits, but the competence of those
regulation modules depends on assembly of CNGA3 with
CNGB3 subunits in heteromeric channels (Dai et al., 2013). This
is likely due to differences in intersubunit coupling between
N- and C-terminal cytoplasmic domains of A3/B3 subunits
vs. A3/A3 subunits (Dai and Varnum, 2013; Dai et al., 2013).
Whether the gating effects produced by T153M are due to altered
intersubunit coupling in heteromeric channels, and whether this
substitution contributes to the retinal pathogenesis, are questions
that necessitate future investigations.
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